Finnish food company Fazer will build a €10.7 million facility in Finland capable of producing xylitol from oat hulls.
FrieslandCampina has opted to offload its Creamy Creation cream liqueur manufacturing business to Wagram Equity Partners, a Dutch private investment company.
Alberta returned to its conservative roots, electing United Conservative Party Leader Jason Kenney premier after he vowed to fight harder for the Canadian province’s beleaguered energy industry.
LifeArc has announced the signing of a deal to license an ion channel drug discovery programme to Daiichi Sankyo.
New AveXis data has reinforced the effectiveness of Novartis’ spinal muscular atrophy (SMA) Type I drug, Zolgensma (onasemnogene abeparvovec-xioi).
Researchers find evidence of rising plastic pollution in an accidental source: log books for plankton-monitoring instruments.
Revival of disembodied organs raises slew of ethical and legal questions about the nature of death and consciousness.
After managing to revive oil prices through production cutbacks, OPEC now risks squandering its victory again by letting crude surge too high.
EVENITY™ (romosozumab-aqqg) now available in the United States for the treatment of osteoporosis in postmenopausal women at high risk for fracture
Amgen (NASDAQ: AMGN) announced that EVENITY™ (romosozumab-aqqg) is now available for shipment to wholesalers in the U.S. EVENITY was approved by the U.S.